Trademarkia Logo

Canada

C$
UZEDY
REGISTERED

on 7 Apr 2025

Last Applicant/ Owned by

Teva Pharmaceuticals USA, Inc.

400 Interpace Parkway, Building AParsippany, NJ 07054

US

Serial Number

2148449 filed on 18th Nov 2021

Registration Number

TMA1304900 registered on 7th Apr 2025

Registration expiry Date

7th Apr 2035

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

UZEDY

Trademark usage description

pharmaceutical preparations for the prevention and treatment of alzheimer's disease; pharmaceutical preparations for the prevention and treatment of d Read More

Classification Information


Class [005]
Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations for human use; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of central nervous system diseases and disorders; Pharmaceutical preparations for the treatment of circulatory system diseases and disorders; Pharmaceutical preparations for the treatment of sensory organ disorders; Pharmaceutical preparations for the treatment of urogenital organ disorders; Pharmaceutical preparations for the treatment of peripheral nervous system disorders; Pharmaceutical preparations for the treatment of neurological disorders.


Classification kind code

11

Mark Details


Serial Number

2148449

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 70
on 11th Dec 2023
Opposed
Submitted for opposition 42
on 11th Oct 2023
Advertised
Submitted for opposition 26
on 13th Sept 2023
Approved
Submitted for opposition 27
on 13th Sept 2023
Approval Notice Sent
Submitted for opposition 22
on 24th Apr 2023
Search Recorded
Submitted for opposition 20
on 24th Apr 2023
Examiner's First Report
Submitted for opposition 287
on 17th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 18th Nov 2021
Filed
Submitted for opposition 1
on 18th Nov 2021
Created
Submitted for opposition 31
on 18th Nov 2021
Formalized